Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.00012 | 1 |